Investor profile
Patient Square Capital has backed 2 European tech companies across 2 funding rounds between 2022 and 2024, joining rounds totalling €141M. Most active in Healthtech. Data as of 7 Aug 2026.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| Resolve Biosciences | Germany | 1 | €72M |
| Nuclera | UK | 1 | €69M |
| Company | Stage | Amount | Date |
|---|---|---|---|
| Resolve Biosciences | Series B | €72M | 2022-10 |
| Nuclera | Series A | €69M | 2024-10 |
